-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CV-301 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CV-301 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CV-301 in Metastatic Colorectal Cancer Drug Details: CV-301 (PANVAC-VF) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 7HP-349 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. 7HP-349 in Solid Tumor Drug Details: 7HP-349 is under development for the treatment of metastatic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rilimogene Galvacirepvec in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rilimogene Galvacirepvec in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Rilimogene Galvacirepvec in Prostate Cancer Drug Details:Rilimogene galvacirepvec (Prostvac) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – 7HP-349
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry 7HP-349 Drug Details 7HP-349 is under development for the treatment of metastatic melanoma, hematopoietic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – XOMA-213
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry XOMA-213 Drug Details XOMA-213 (LFA-102) is under development for the treatment of various hyperprolactinemias....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – rilimogene galvacirepvec
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry rilimogene galvacirepvec Drug Details Rilimogene galvacirepvec (Prostvac) is under development for the treatment of...
-
Product Insights
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture, and chest radiography. For rapid diagnosis, polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test, and rapid culture systems are performed. The Mycobacterium tuberculosis tests pipeline market research report provides comprehensive information about the Mycobacterium tuberculosis tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020
COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. GlobalData's Medical Devices sector report, “COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
Wind Turbines, Update 2017 – Global Market Size, Competitive Landscape, and Key Country Analysis to 2021
GlobalData's latest report "Wind Turbines, Update 2017 - Global Market Size, Competitive Landscape, and Key Country Analysis to 2021" offers comprehensive information and understanding of the global wind turbines equipment market. The report analyzes the current trend and future potential of wind turbines equipment market at global, regional (Asia-Pacific, Europe, North America, South and Central America, and Middle East and Africa) and key countries (the US, China, India, Germany, UK, France, Brazil, Mexico, Turkey, Canada, and South Africa) level. The...